Franco Momoli

PhD, MSc

Acting Practice Lead, Chemical and Product Safety

Joined RSI in 2019

  • Canada

    Country of Residence

Franco Momoli

Personal Introduction

My love of epidemiology, statistical methods, and the risk sciences developed in a, perhaps, second phase of my life. I began my research career in the animal sciences, where my interest in successful human aging was sparked by a fascinating book written by Caleb Finch (Longevity, Senescence, and the Genome), and this interest led to involvement in studies of Alzheimer’s Disease – some of my early research involved behavioural and cognitive testing of an early transgenic mouse model of Alzheimer’s. This is work I conducted while a graduate student at McGill University and at the Douglas Hospital Research Institute. My career, however, has been as an epidemiologist and biostatistician. I trained and worked with several research groups that studied cancer etiology. Much of my academic life has been spent on (as I once heard described) “smuggling statistical methods” into epidemiology, including ideas around semi-Bayesian models and quantitative bias modelling, all in an effort to provide better and more robust answers to our research questions.

Franco Momoli: Promotion to Associate Professor, School of Epidemiology and Public Health, University of Ottawa

As a professor at the University of Ottawa, I taught and mentored many graduate students. I was one of the principal scientists for Canada in the multinational MOBI-Kids study of brain tumours and youth, addressing a worldwide concern with non-ionizing radiation from cell phone use.

I spent a decade working at the research institutes of The Ottawa Hospital and the Children’s Hospital of Eastern Ontario (CHEO), collaborating on multiple research teams and addressing diverse clinical questions. My work covered the breadth of adult and child health, including diagnostic and screening studies, randomized trials of novel interventions, systematic and scoping reviews for knowledge synthesis, knowledge gathering via survey design, and explanatory research with secondary use of health data. During this time I also served as a member of the Ottawa Hospital Research Ethics Board, a member and interim chair of the CHEO Research Ethics Board, and a member of CHEO’s Policy Ethics Board.

Franco Momoli

Dr. Momoli, who believes teaching is a vocation, giving one of his many and regular lectures.

Franco Momoli: Current Focus

Dr. Momoli is the acting Practice Lead for Chemical and Product Safety at Risk Sciences International, as well as an adjunct professor in the School of Epidemiology and Public Health at the University of Ottawa.

Works and Accomplishments

While with RSI as a practice lead, Dr. Momoli has led projects for various international organizations and agencies, including projects on diverse topics, such as international prioritization strategies during an influenza pandemic, use of consumer products in the workplace, screening of indoor semi-volatile organic compounds, prioritization of air pollutants, and updates of hazard assessments for aluminium and aluminium nanoproducts.

Dr. Momoli’s published work has involved statistical methods for addressing multiple exposures (Momoli et al., 2010) and bias modelling approaches (Momoli et al., 2017) and bias quantification (Turner et al., 2019). He has collaborated on a wide swath of clinical research topics, including determination of death in children following withdrawal of life support (Dhanani et al., 2014); aboriginal child health (Young et al., 2018); depression in the military (Theriault et al., 2019); sleep disordered breathing in children (Blinder et al., 2020; Tsampalieros et al., 2019); tuberculosis in Nunavut (Alvarez et al., 2014; Kilabuk et al., 2020); delirium in palliative care settings (Watt et al., 2019; Lawlor et al., 2014); stroke and free floating thrombus prediction (Dowlatshahi et al., 2014); antifibrinolytic use to reduce the need for blood transfusions during cystectomies for bladder cancer (Punjani et al., 2013; Breau et al., 2018); and early approaches to recovery in youth with concussions (Grool et al., 2016; Bresee et al., 2018; Gravel et al., 2018).

Franco Momoli: Extra-curricular

Franco organizing a dragon boat

In his spare time, Franco Momoli loves classic literature, kayaking, all things coffee, and studying and practicing Aikido.

Please enter your name.
Please enter a subject.
Please enter a message.
Please check the captcha to verify you are not a robot.
  • 0%

    99% of our added value is our staff.

RSIepidemiologiststoxicologistsmedical doctorsengineersprogrammerssoftware engineerseditorstranslatorscampaignerscommunicatorsperception analystspolicy expertsregulatory advisorschemistsbiologistsclimate expertsurban expertspublic health specialistsmathematicianstrainers

Donald Mattison

Dr. Donald Mattison was appointed Chief Medical Officer and Senior Vice President of Risk Sciences International in 2012. Dr. Mattison also serves as Associate Director of the McLaughlin Centre for Population Health Risk Assessment and as Adjunct Professor at the School of Epidemiology and Public Health at the University of Ottawa. He is also Medical Advisor to QuarterWatch: Monitoring FDA MedWatch Reports published by the Institute for Safe Medication Practices in Horsham, Pennsylvania.

Full Bio...

Greg Paoli

As RSI’s Principal Risk Scientist and COO, Greg Paoli is currently working with a broad spectrum of clients in the public and private sectors, with the greatest emphasis on the development of new approaches to transform regulatory systems to be more “risk-based” at multiple levels: how senior decision-makers process risk information and make the “tough choices” in regulating health and safety, how an organization can optimize its resources across a diverse mandate to maximize total “portfolio-level” risk reduction, and how to operationalize key resources like the scheduling of inspections when faced with thousands of inspection targets, but not enough resources to inspect all of them.

Full Bio...

Todd Ruthman

Todd Ruthman’s current focus is on tools that help regulators visualize and understand the public risk burden within their mandates to help inform risk-based decisions. Mr. Ruthman provides design, management, modelling, coding, and database development expertise for these tools. Mr. Ruthman also manages the RSI development group enhancing previously released tools…

Full Bio...

Anne Wiles

For her work at RSI, Anne has built on her previous experience and academic research through work on communication on nuclear power and nuclear waste disposal; developing communication strategies and messaging on health risk issues; and delivering training on risk communication. She has also applied her familiarity with risk regulation in many projects on government…

Full Bio...

Michael G. Tyshenko

Dr. Tyshenko is involved with various health risk issues and is the lead on chemical peer reviews at RSI. He continues international research on infectious disease health policy and evidence-based decision-making for SARS, MERS and COVID-19 with a collaborative working group from China, USA, and the UAE. Other ongoing work in Nepal with the Ministry of Health in collaboration…

Full Bio...

Natalia (Natasha) Shilnikova

At RSI, Dr. Natalia (Natasha) Shilnikova has been working on projects involving toxicology, epidemiology and human health risk assessment, such as development of toxicity profiles for several chemicals on Health Canada’s Domestic Substances List (DSL); a systematic review of potential cancer and reproductive risks of artificial sweeteners for the International…

Full Bio...

Martin LeBlanc

Mr. Martin LeBlanc is responsible for growing RSI’s book of business, supporting all activities to this end. His line is always open to assist clients old and new. He strives to understand and provide a client’s unique need on a project, having done so for many government and private clients across the health, nuclear, power generation, aerospace, manufacturing, transportation and national defence sectors.

Full Bio...

Siva Ramoju

Siva Ramoju holds Masters Degrees in Biotechnology as well as Cellular Toxicology. His previous and present work in cellular toxicology has provided him with training and research experience in understanding how chemicals can damage individual cells, and an understanding of toxicity from the perspective of the whole animal.

Full Bio...

Daniel Krewski

Dr. Krewski serves as Chief Risk Scientist and CEO of Risk Sciences International. He also holds academic appointments as Professor in the School of Epidemiology and Public Health and Scientific Director of the McLaughlin Centre for Population Health Risk Assessment in the Faculty of Medicine at the University of Ottawa. Dr. Krewski is a Fellow of the Society of Risk Analysis and the American Statistical Association, and a lifetime National Affiliate of the US National Academy of Sciences. In 2013, he received the Distinguished Achievement Award from the Society for Risk Analysis, for excellent performance in the practice of risk analysis. He has contributed to over 900 scientific and technical publications in the field of risk science during the course of his career to date.

Full Bio...

Jennifer Go

Jennifer joined RSI in August of 2017 as a Risk Analyst with specialization in epidemiology. She possesses a diverse set of skills that contributes to her flexibility to work on a wide range of scientific projects. In particular, Jennifer has research experience in programming using SAS, manipulating large datasets, constructing statistical models, interpreting quantitative data, …

Full Bio...

Nataliya Karyakina

Dr. Nataliya Karyakina has solid knowledge and extensive experience in hazard identification and human health risk assessments of toxic chemicals present in air, water, food and consumer products. Her research focuses on multidisciplinary studies of potential adverse health effects.

Full Bio...

Emma Hartnett

Dr. Hartnett currently works on the development of risk-based decision-making processes and tools to support public risk assessment. Current focus includes: working with the Canadian Food Inspection Agency exploring methodologies to support risk-based monitoring of contaminants in food; working with Transport Canada to develop guidelines and methodologies to support risk-based decisions related to public risks from the transportation system; working with the U.S. Food and Drug Administration on continuing expansions and improvements to the FDA-iRISK tool.

Full Bio...

Hong Duan

Since joining RSI’s technical team in 2011, Hong has focused on developing risk-based database-driven web projects. Her extensive knowledge and experience, has helped RSI to develop high quality software for multiple clients including the Public Health Agency of Canada, the U.S. Food and Drug Administration, the Food and Agriculture Organization of the United Nations based in Rome, and the World Health Organization based in Geneva.

Full Bio...

Cemil ‘Jim’ Alyanak

Now serving as RSI’s Vice-President Communications and Strategic Initiatives, for years Cemil has provided organizations with guidance designed to transmit mission-critical messages. An anti-tobacco campaign is not about promoting a strategy, it’s about saving lives. Get the message wrong and people die. That type of commitment to results is what Cemil brings to Risk Sciences International.

Full Bio...